Heart Rhythm
Volume 7, Issue 2 , Pages 208-215 , February 2010

Diagnostic utility of bipolar precordial leads during ajmaline testing for suspected Brugada syndrome

  • Velislav N. Batchvarov, MD

      Affiliations

    • Division of Cardiac and Vascular Sciences, St. George's University of London, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Velislav N. Batchvarov, Division of Cardiac and Vascular Sciences, St. George's University of London, Cranmer Terrace, London SW17 0RE, United Kingdom
    • ,
  • Malini Govindan, BMed, FRACP

      Affiliations

    • Division of Cardiac and Vascular Sciences, St. George's University of London, London, United Kingdom
    • ,
  • Peter Macfarlane, DSc, FRCP (Glasg), FESC, FRSE

      Affiliations

    • University Department of Medical Cardiology, Royal Infirmary, Glasgow, Scotland
    • ,
  • A. John Camm, MD, FRCP, FESC, FAHA, FHRS

      Affiliations

    • Division of Cardiac and Vascular Sciences, St. George's University of London, London, United Kingdom
    • ,
  • Elijah R. Behr, MD, MRCP

      Affiliations

    • Division of Cardiac and Vascular Sciences, St. George's University of London, London, United Kingdom

Received 8 June 2009 ,Accepted 5 October 2009.

References 

  1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391–1396
  2. Wilde AAM, Antzelevitch C, Borggrefe M, et al. Consensus report (Proposed diagnostic criteria for the Brugada syndrome). Eur Heart J. 2002;23:1648–1554
  3. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome (Report of the Second Consensus Conference). Circulation. 2005;111:659–670
  4. Benito B, Brugada R, Brugada J, Brugada P. Brugada syndrome. Prog Cardiovasc Dis. 2008;51:1–22
  5. Roesler H. An electrocardiographic study of high take-off of the R(R′)-T segment in right precordial leads. Am J Cardiol. 1960;6:920–928
  6. Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol. 2000;11:396–404
  7. Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, Sitthisook S, Tosukhowong P, Tungsanga K. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J. 2001;22:2290–2296
  8. Teijeiro R, Garro HA, Acunzo RS, Albino E, Chiale PA. Recording of high V1-V3 precordial leads may be essential to the diagnosis of Brugada syndrome during the ajmaline test. J Cardiovasc Pharmacol Ther. 2006;11:153–155
  9. Nakazawa K, Sakurai T, Takagi A, et al. Clinical significance of electrocardiography recordings from a higher intercostal space for detection of the Brugada sign. Circ J. 2004;68:1018–1022
  10. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AAM, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol. 2006;17:857–864
  11. Miyamoto K, Yokokawa M, Tanaka K, et al. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men With Brugada syndrome. Am J Cardiol. 2007;99:53–57
  12. Brugada P. Amid the fourth lustrum after the description of Brugada syndrome: controversies over?. Europace. 2009;11:412–413
  13. Watanabe H, Koopmann TT, Le Scouarnec S, et al. Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118:2260–2268
  14. Morita M, Zipes DP, Wu J. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations. Heart Rhythm. 2009;6:S34–S43
  15. Yan G-X, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660–1666
  16. Yan G-X, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation. 1998;98:1921–1927
  17. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol. 2001;12:268–272
  18. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol. 2002;40:330–334
  19. Shimizu W, Aiba T, Kurita T, Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol. 2001;12:1418–1421
  20. Narayan SM, Kim J, Tate C, Berman BJ. Steep restitution of ventricular action potential duration and conduction slowing in human Brugada syndrome. Heart Rhythm. 2007;4:1087–1089
  21. Aiba T, Shimizu W, Hidaka I, et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model high-resolution optical mapping study. J Am Coll Cardiol. 2006;47:2074–2085
  22. Lambiase PD, Ahmed AK, Ciaccio EJ, et al. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation. 2009;120:106117
  23. Nagase S, Kusano KF, Morita H, et al. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol. 2008;51:1154–1161
  24. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome (A combined electrophysiological, genetic, histopathologic, and computational study). Circulation. 2005;112:2769–2777
  25. Nagase S, Kusano KF, Morita H, et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome (Using the epicardial lead). J Am Coll Cardiol. 2002;39:1992–1995
  26. Furushima H, Chinushi M, Hirono T, et al. Relationship Between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome. J Cardiovasc Electrophysiol. 2005;16:1311–1317
  27. Huang Z, Patel C, Li W, et al. Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm. 2009;6:1156–1162
  28. Morita H, Kusano KF, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008;118:1697–1704
  29. Meregalli PG, Wilde AAM, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res. 2005;67:367–378
  30. Chinushi M, Izumi D, Furushima H, Watanabe H, Aizawa Y. Multiple premature beats triggered ventricular arrhythmias during pilsicainide infusion in a patient with inferior ST-segment elevation. Pacing Clin Electrophysiol. 2006;29:1445–1448
  31. Riera AR, Ferreira C, Schapachnik E, Sanches PC, Moffa PJ. Brugada syndrome with atypical ECG: downsloping ST-segment elevation in inferior leads. J Electrocardiol. 2004;37:101–104
  32. Rautaharju P, Rautaharju F. Investigative Electrocardiography in Epidemiological Studies and Clinical Trials. London: Springer-Verlag. 2007;18–28
  33. Macfarlane PW. Age, sex, and the ST amplitude in health and disease. J Electrocardiol. 2001;4(Suppl):235–241

 Supported in part by the British Heart Foundation.

PII: S1547-5271(09)01149-7

doi: 10.1016/j.hrthm.2009.10.005

Heart Rhythm
Volume 7, Issue 2 , Pages 208-215 , February 2010

Article Tools

* Image Usage & Resolution